These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

252 related articles for article (PubMed ID: 2546488)

  • 1. Comparative evaluation of daptomycin (LY146032) and vancomycin in the treatment of experimental methicillin-resistant Staphylococcus aureus osteomyelitis in rabbits.
    Mader JT; Adams K
    Antimicrob Agents Chemother; 1989 May; 33(5):689-92. PubMed ID: 2546488
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Treatment of chronic experimental Staphylococcus aureus osteomyelitis with LY146032 and vancomycin.
    Luu QN; Buxton TB; Nelson DR; Rissing JP
    Eur J Clin Microbiol Infect Dis; 1989 Jun; 8(6):562-3. PubMed ID: 2548867
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Efficacy of daptomycin combined with rifampicin for the treatment of experimental meticillin-resistant Staphylococcus aureus (MRSA) acute osteomyelitis.
    Lefebvre M; Jacqueline C; Amador G; Le Mabecque V; Miegeville A; Potel G; Caillon J; Asseray N
    Int J Antimicrob Agents; 2010 Dec; 36(6):542-4. PubMed ID: 20851576
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Comparative evaluation of tigecycline and vancomycin, with and without rifampicin, in the treatment of methicillin-resistant Staphylococcus aureus experimental osteomyelitis in a rabbit model.
    Yin LY; Lazzarini L; Li F; Stevens CM; Calhoun JH
    J Antimicrob Chemother; 2005 Jun; 55(6):995-1002. PubMed ID: 15857944
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Daptomycin treatment of Staphylococcus aureus experimental chronic osteomyelitis.
    Rouse MS; Piper KE; Jacobson M; Jacofsky DJ; Steckelberg JM; Patel R
    J Antimicrob Chemother; 2006 Feb; 57(2):301-5. PubMed ID: 16361330
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Comparison of the investigational drug, LY146032, with vancomycin in experimental pneumonia due to methicillin-resistant Staphylococcus aureus.
    Kephart PA; Esposito AL
    J Antimicrob Chemother; 1988 Jan; 21(1):33-9. PubMed ID: 2833488
    [TBL] [Abstract][Full Text] [Related]  

  • 7. In vivo assessment of the antimicrobial activity of a calcium-deficient apatite vancomycin drug delivery system in a methicillin-resistant Staphylococcus aureus rabbit osteomyelitis experimental model.
    Amador G; Gautier H; Le Mabecque V; Miegeville AF; Potel G; Bouler JM; Weiss P; Caillon J; Jacqueline C
    Antimicrob Agents Chemother; 2010 Feb; 54(2):950-2. PubMed ID: 19933800
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Efficacy of telavancin in the treatment of methicillin-resistant Staphylococcus aureus osteomyelitis: studies with a rabbit model.
    Yin LY; Calhoun JH; Thomas TS; Wirtz ED
    J Antimicrob Chemother; 2009 Feb; 63(2):357-60. PubMed ID: 19060292
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Efficacy of NEMO-binding domain peptide used to treat experimental osteomyelitis caused by methicillin-resistant
    Xu CP; Chen Y; Sun HT; Cui Z; Yang YJ; Huang L; Yu B; Wang FZ; Yang QP; Qi Y
    Antimicrob Resist Infect Control; 2019; 8():182. PubMed ID: 31832182
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Efficacy of the new cephalosporin ceftaroline in the treatment of experimental methicillin-resistant Staphylococcus aureus acute osteomyelitis.
    Jacqueline C; Amador G; Caillon J; Le Mabecque V; Batard E; Miègeville AF; Biek D; Ge Y; Potel G; Hamel A
    J Antimicrob Chemother; 2010 Aug; 65(8):1749-52. PubMed ID: 20530506
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Vancomycin-loaded nano-hydroxyapatite pellets to treat MRSA-induced chronic osteomyelitis with bone defect in rabbits.
    Jiang JL; Li YF; Fang TL; Zhou J; Li XL; Wang YC; Dong J
    Inflamm Res; 2012 Mar; 61(3):207-15. PubMed ID: 22159524
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Intermediate vancomycin susceptibility in a community-associated MRSA clone.
    Graber CJ; Wong MK; Carleton HA; Perdreau-Remington F; Haller BL; Chambers HF
    Emerg Infect Dis; 2007 Mar; 13(3):491-3. PubMed ID: 17552110
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Comparative evaluation of cefazolin and clindamycin in the treatment of experimental Staphylococcus aureus osteomyelitis in rabbits.
    Mader JT; Adams K; Morrison L
    Antimicrob Agents Chemother; 1989 Oct; 33(10):1760-4. PubMed ID: 2589843
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Comparative evaluation of A-56619, A-56620, and nafcillin in the treatment of experimental Staphylococcus aureus osteomyelitis.
    Mader JT; Morrison LT; Adams KR
    Antimicrob Agents Chemother; 1987 Feb; 31(2):259-63. PubMed ID: 3566251
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Daptomycin compared with teicoplanin and vancomycin for therapy of experimental Staphylococcus aureus endocarditis.
    Kaatz GW; Seo SM; Reddy VN; Bailey EM; Rybak MJ
    Antimicrob Agents Chemother; 1990 Nov; 34(11):2081-5. PubMed ID: 1963526
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Activity of Tedizolid in Methicillin-Resistant Staphylococcus aureus Experimental Foreign Body-Associated Osteomyelitis.
    Park KH; Greenwood-Quaintance KE; Mandrekar J; Patel R
    Antimicrob Agents Chemother; 2016 Nov; 60(11):6568-6572. PubMed ID: 27550347
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Influence of daptomycin on staphylococcal abscesses and experimental tobramycin nephrotoxicity.
    Wood CA; Finkbeiner HC; Kohlhepp SJ; Kohnen PW; Gilbert DN
    Antimicrob Agents Chemother; 1989 Aug; 33(8):1280-5. PubMed ID: 2552905
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Adjunctive rifampin is crucial to optimizing daptomycin efficacy against rabbit prosthetic joint infection due to methicillin-resistant Staphylococcus aureus.
    Saleh-Mghir A; Muller-Serieys C; Dinh A; Massias L; Crémieux AC
    Antimicrob Agents Chemother; 2011 Oct; 55(10):4589-93. PubMed ID: 21825285
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Daptomycin is more efficacious than vancomycin against a methicillin-susceptible Staphylococcus aureus in experimental meningitis.
    Gerber P; Stucki A; Acosta F; Cottagnoud M; Cottagnoud P
    J Antimicrob Chemother; 2006 Apr; 57(4):720-3. PubMed ID: 16459345
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Effectiveness of hydroxyapatite-vancomycin bone cement in the treatment of Staphylococcus aureus induced chronic osteomyelitis.
    Joosten U; Joist A; Gosheger G; Liljenqvist U; Brandt B; von Eiff C
    Biomaterials; 2005 Sep; 26(25):5251-8. PubMed ID: 15792552
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.